Plasma uric acid and tumor volume are highly predictive of outcome in nasopharyngeal carcinoma patients receiving intensity modulated radiotherapy
Open Access
- 15 May 2013
- journal article
- research article
- Published by Springer Science and Business Media LLC in Radiation Oncology
- Vol. 8 (1), 121
- https://doi.org/10.1186/1748-717x-8-121
Abstract
The combined predictive value of plasma uric acid and primary tumor volume in nasopharyngeal carcinoma (NPC) patients receiving intensity modulated radiation therapy (IMRT) has not yet been determined. In this retrospective study, plasma uric acid level was measured after treatment in 130 histologically-proven NPC patients treated with IMRT. Tumor volume was calculated from treatment planning CT scans. Overall (OS), progression-free (PFS) and distant metastasis-free (DMFS) survival were compared using Kaplan-Meier analysis and the log rank test, and Cox multivariate and univariate regression models were created. Patients with a small tumor volume (301 μmol/L) had a better DMFS, PFS and OS than patients with a low post-treatment plasma uric acid level. Patients with a small tumor volume and high post-treatment plasma uric acid level had a favorable prognosis compared to patients with a large tumor volume and low post-treatment plasma uric acid level (7-year overall OS, 100% vs. 48.7%, P P <0.001). Post-treatment plasma uric acid level and pre-treatment tumor volume have predictive value for outcome in NPC patients receiving IMRT. NPC patients with a large tumor volume and low post-treatment plasma uric acid level may benefit from additional aggressive treatment after IMRT.Keywords
This publication has 20 references indexed in Scilit:
- Factors contributing to the efficacy of concurrent–adjuvant chemotherapy for locoregionally advanced nasopharyngeal carcinoma: Combined analyses of NPC-9901 and NPC-9902 TrialsEuropean Journal Of Cancer, 2011
- Significance of Primary Tumor Volume and T-stage on Prognosis in Nasopharyngeal Carcinoma Treated with Intensity-modulated Radiation TherapyJapanese Journal of Clinical Oncology, 2011
- Local control, survival, and late toxicities of locally advanced nasopharyngeal carcinoma treated by simultaneous modulated accelerated radiotherapy combined with cisplatin concurrent chemotherapyCancer, 2010
- Intensity-Modulated Radiation Therapy With or Without Chemotherapy for Nasopharyngeal Carcinoma: Radiation Therapy Oncology Group Phase II Trial 0225Journal of Clinical Oncology, 2009
- Treatment Outcomes After Radiotherapy Alone for Patients With Early-Stage Nasopharyngeal CarcinomaInternational Journal of Radiation Oncology*Biology*Physics, 2009
- Local and systemic oxidant/antioxidant status before and during lung cancer radiotherapyFree Radical Research, 2009
- Prognostic Impact of Primary Tumor Volume in Patients With Nasopharyngeal Carcinoma Treated by Definitive Radiation TherapyThe Laryngoscope, 2008
- The effect of primary tumor volumes in advanced T‐staged nasopharyngeal tumorsHead & Neck, 2002
- Protection of DNA from radiation-induced double-strand breaks: influence of replication and nuclear proteinsInternational Journal of Radiation Biology, 2000
- Uric acid provides an antioxidant defense in humans against oxidant- and radical-caused aging and cancer: a hypothesis.Proceedings of the National Academy of Sciences of the United States of America, 1981